Skip to main content
Caplight Logo









jVen Capital

jVen Capital

Jackson, Wyomingjvencapital.com

Overview

jVen Capital is a US-based venture capital and growth equity firm founded in 2007 that invests in the life sciences, personalized medicine, genetics, medical devices, and digital health sectors.

Year Founded

2007

Portfolio Companies

2

Investments

jVen Capital investments
CompanyDateStageLead
KyvernaAug 2023Series BCo-investor
SunwinkApr 2021SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is jVen Capital based?

jVen Capital is headquartered in Jackson, Wyoming, United States.

When was jVen Capital founded?

jVen Capital was founded in 2007.

How many portfolio companies does jVen Capital have?

jVen Capital has 2 portfolio companies in Caplight's dataset.

What are some companies in jVen Capital's portfolio?

Portfolio companies visible on Caplight include Kyverna, Sunwink.

What was jVen Capital's most recent investment shown here?

jVen Capital's most recent investment in this portfolio sample was in Kyverna in 2023.

What sectors does jVen Capital focus on?

jVen Capital focuses on Consumer & Commerce, Healthcare & Life Sciences.

What company stages does jVen Capital focus on?

jVen Capital typically invests at the Early stage.

Firmographic Details

HeadquartersJackson, Wyoming
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?